TD Cowen lowered the firm’s price target on Science 37 to $2.50 from $3.00 and keeps an Outperform rating on the shares. The analyst updated his model to reflect 4Q results and management’s 2023 guidance. TD Cowen said while we believe in outlook for DCT, the near-term outlook for the company reflects still early innings for the space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNCE:
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Science 37 price target lowered to $1.00 from $2.00 at Baird
- Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results
- Science 37 sees FY23 revenue $55M-$60M, consensus $73.66M
- Science 37 reports Q4 EPS (57c), consensus (18c)